Definitive Healthcare Corp (NASDAQ: DH)’s stock price has increased by 0.23 compared to its previous closing price of 4.31. However, the company has seen a 3.35% increase in its stock price over the last five trading sessions. zacks.com reported 2024-11-07 that Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.09 per share a year ago.
Is It Worth Investing in Definitive Healthcare Corp (NASDAQ: DH) Right Now?
The stock has a 36-month beta value of 1.35. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 5 as “overweight,” 8 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for DH is 46.98M, and at present, short sellers hold a 5.91% of that float. On November 08, 2024, the average trading volume of DH was 571.81K shares.
DH’s Market Performance
The stock of Definitive Healthcare Corp (DH) has seen a 3.35% increase in the past week, with a 0.23% rise in the past month, and a 15.82% gain in the past quarter. The volatility ratio for the week is 4.57%, and the volatility levels for the past 30 days are at 3.57% for DH. The simple moving average for the past 20 days is 0.36% for DH’s stock, with a -28.33% simple moving average for the past 200 days.
Analysts’ Opinion of DH
Many brokerage firms have already submitted their reports for DH stocks, with BTIG Research repeating the rating for DH by listing it as a “Buy.” The predicted price for DH in the upcoming period, according to BTIG Research is $7 based on the research report published on September 17, 2024 of the current year 2024.
JP Morgan, on the other hand, stated in their research note that they expect to see DH reach a price target of $5, previously predicting the price at $7. The rating they have provided for DH stocks is “Underweight” according to the report published on July 31st, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to DH, setting the target price at $9 in the report published on May 08th of the current year.
DH Trading at -1.06% from the 50-Day Moving Average
After a stumble in the market that brought DH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.32% of loss for the given period.
Volatility was left at 3.57%, however, over the last 30 days, the volatility rate increased by 4.57%, as shares surge +2.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.44% lower at present.
During the last 5 trading sessions, DH rose by +8.13%, which changed the moving average for the period of 200-days by -50.92% in comparison to the 20-day moving average, which settled at $4.31. In addition, Definitive Healthcare Corp saw -56.54% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for DH
Current profitability levels for the company are sitting at:
- -0.96 for the present operating margin
- 0.68 for the gross margin
The net margin for Definitive Healthcare Corp stands at -1.42. The total capital return value is set at -0.24. Equity return is now at value -48.99, with -22.96 for asset returns.
Based on Definitive Healthcare Corp (DH), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at 5.08. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -31.63.
Currently, EBITDA for the company is 20.84 million with net debt to EBITDA at 1.38. When we switch over and look at the enterprise to sales, we see a ratio of 1.45. The receivables turnover for the company is 7.16for trailing twelve months and the total asset turnover is 0.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.31.
Conclusion
To sum up, Definitive Healthcare Corp (DH) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
